Ruthigen's IPO

Ruthigen raised a round of funding on March 21, 2014. Investors include Public.

Ruthigen is a biopharmaceutical company focused on the discovery, development, and commercialization of pharmaceutical-grade hypochlorous acid-based (HOCl) therapeutics designed to prevent and treat i…

Articles about Ruthigen's IPO: